You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / HIKAL LTD

HIKAL LTD Analysis

Returns | 1W : -2% , 1M : 1.5%,1Y : 27.9%
BOM : 524735     NSE : HIKAL    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Jan 25,2021
Price(EOD): Rs. 168.75
This is the End-of-Day (EOD) Stock Price updated daily by 10 pm IST.
MarketCap: Rs. 2,080.69 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
HIKAL LTD -2% 1.5% 27.9%
SUN PHARMACEUTICAL INDUSTRIES LTD -1.6% -0.6% 27.8%
DR REDDYS LABORATORIES LTD -0.1% -2.3% 65.7%
DIVIS LABORATORIES LTD -0.9% -4.8% 86.8%
CIPLA LTD 1.8% 0.4% 73.9%
BIOCON LTD -15.3% -20.6% 33.9%
AUROBINDO PHARMA LTD 8% 9.8% 88.7%
LUPIN LTD -0.8% 10.8% 46.3%
TORRENT PHARMACEUTICALS LTD -4.2% -5.3% 33.1%

FUNDAMENTAL ANALYSIS OF HIKAL LTD

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than HIKAL LTDPremium

As on 25-Jan-2021, the Fundamentals of HIKAL LTD are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of HIKAL LTD. Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!


VALUATION OF HIKAL LTD

 
Valuation Score
RatioValue
P/E
P/B
P/S
24.64
P/E Calculated based on EPS of 6.85
[ Mar2020 - Standalone Results ]

2.55
P/B Calculated based on Book Value of 66.22
[ Mar2020 - Standalone Results ]

1.43
P/S Calculated based on Revenues of 1456.87 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than HIKAL LTDPremium

As on 25-Jan-2021, HIKAL LTD is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!


INTRINSIC VALUE OF HIKAL LTD

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
17%
-7%
17%

As on 25-Jan-2021, the Intrinsic Value of HIKAL LTD is Rs. 144.15 determined based on Median of the 3 historical models.
Fair Value based on Median EV / EBIDTA Model : Rs. 144.14
Fair Value based on Median EV / Sales Model : Rs. 181.30
Fair Value based on Median Price / Sales Model : Rs. 144.15
Median Fair Value of HIKAL LTD : Rs. 144.15

As on 25-Jan-2021, HIKAL LTD is trading at a Premium of 17% based on the Median Intrinsic Value!


SHARE PRICE MOMENTUM OF HIKAL LTD

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.79
0.87
0.95
0.87
0.79
0.87
0.95
0.87
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
5.43%
33.13%
80.12%
79.67%
15.84%
19.5%
323.63%
323.08%
QtrlyTrend
8
Latest Qtr: Sep2020




Open Demat Account & Start Investing
    Affiliate Links

Disclosure

The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z